Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 6
2007 5
2008 5
2009 5
2010 4
2011 1
2013 5
2014 3
2018 1
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Results by year
Filters applied: . Clear all
Page 1
Epigenetic activation of POTE genes in ovarian cancer.
Sharma A, Albahrani M, Zhang W, Kufel CN, James SR, Odunsi K, Klinkebiel D, Karpf AR. Sharma A, et al. Epigenetics. 2019 Feb;14(2):185-197. doi: 10.1080/15592294.2019.1581590. Epub 2019 Mar 4. Epigenetics. 2019. PMID: 30764732 Free PMC article.
Expression of the POTE gene family in human ovarian cancer.
Barger CJ, Zhang W, Sharma A, Chee L, James SR, Kufel CN, Miller A, Meza J, Drapkin R, Odunsi K, Klinkebiel D, Karpf AR. Barger CJ, et al. Sci Rep. 2018 Nov 20;8(1):17136. doi: 10.1038/s41598-018-35567-1. Sci Rep. 2018. PMID: 30459449 Free PMC article.
Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy.
Akers SN, Odunsi K, Karpf AR. Akers SN, et al. Future Oncol. 2010 May;6(5):717-32. doi: 10.2217/fon.10.36. Future Oncol. 2010. PMID: 20465387 Free PMC article. Review.
SGI-110: DNA Methyltransferase Inhibitor Oncolytic.
Griffiths EA, Choy G, Redkar S, Taverna P, Azab M, Karpf AR. Griffiths EA, et al. Drugs Future. 2013 Aug;38(8):535-543. Drugs Future. 2013. PMID: 26190889 Free PMC article.
A potential role for epigenetic modulatory drugs in the enhancement of cancer/germ-line antigen vaccine efficacy.
Karpf AR. Karpf AR. Epigenetics. 2006 Jul-Sep;1(3):116-20. doi: 10.4161/epi.1.3.2988. Epigenetics. 2006. PMID: 17786175 Free PMC article. Review.
An improved synthesis of psammaplin A.
Godert AM, Angelino N, Woloszynska-Read A, Morey SR, James SR, Karpf AR, Sufrin JR. Godert AM, et al. Bioorg Med Chem Lett. 2006 Jun 15;16(12):3330-3. doi: 10.1016/j.bmcl.2006.03.008. Epub 2006 May 2. Bioorg Med Chem Lett. 2006. PMID: 16632351
Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer.
Odunsi K, Matsuzaki J, James SR, Mhawech-Fauceglia P, Tsuji T, Miller A, Zhang W, Akers SN, Griffiths EA, Miliotto A, Beck A, Batt CA, Ritter G, Lele S, Gnjatic S, Karpf AR. Odunsi K, et al. Cancer Immunol Res. 2014 Jan;2(1):37-49. doi: 10.1158/2326-6066.CIR-13-0126. Cancer Immunol Res. 2014. PMID: 24535937 Free PMC article. Clinical Trial.
Epigenomic reactivation screening to identify genes silenced by DNA hypermethylation in human cancer.
Karpf AR. Karpf AR. Curr Opin Mol Ther. 2007 Jun;9(3):231-41. Curr Opin Mol Ther. 2007. PMID: 17608021 Review.
Immunomodulatory action of SGI-110, a hypomethylating agent, in acute myeloid leukemia cells and xenografts.
Srivastava P, Paluch BE, Matsuzaki J, James SR, Collamat-Lai G, Karbach J, Nemeth MJ, Taverna P, Karpf AR, Griffiths EA. Srivastava P, et al. Leuk Res. 2014 Nov;38(11):1332-41. doi: 10.1016/j.leukres.2014.09.001. Epub 2014 Sep 10. Leuk Res. 2014. PMID: 25260825 Free PMC article.
BORIS/CTCFL mRNA isoform expression and epigenetic regulation in epithelial ovarian cancer.
Link PA, Zhang W, Odunsi K, Karpf AR. Link PA, et al. Cancer Immun. 2013;13:6. Epub 2013 Jan 22. Cancer Immun. 2013. PMID: 23390377 Free PMC article.
33 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback